Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

Disease recurrence (locoregional, distant) exerts a significant clinical impact on the survival of estrogen receptor–positive breast cancer patients. Many of these recurrences occur late, more than 5 years after original diagnosis, and represent a major obstacle to the effective treatment of this di...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowling, Ryan J O, Kalinsky, Kevin, Hayes, Daniel F, Bidard, Francois-Clement, Cescon, David W, Chandarlapaty, Sarat, Deasy, Joseph O, Dowsett, Mitch, Gray, Robert J, Henry, N Lynn, Meric-Bernstam, Funda, Perlmutter, Jane, Sledge, George W, Bratman, Scott V, Carey, Lisa A, Chang, Martin C, DeMichele, Angela, Ennis, Marguerite, Jerzak, Katarzyna J, Korde, Larissa A, Lohmann, Ana Elisa, Mamounas, Eleftherios P, Parulekar, Wendy R, Regan, Meredith M, Schramek, Daniel, Stambolic, Vuk, Thorat, Mangesh A, Whelan, Timothy J, Wolff, Antonio C, Woodgett, Jim R, Sparano, Joseph A, Goodwin, Pamela J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049988/
https://www.ncbi.nlm.nih.gov/pubmed/32337479
http://dx.doi.org/10.1093/jncics/pkz050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049988/
https://www.ncbi.nlm.nih.gov/pubmed/32337479
http://dx.doi.org/10.1093/jncics/pkz050

Ejemplares similares